Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London stocks slip on fears of second virus wave; BP slides

Mon, 15th Jun 2020 09:29

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* BP tumbles on writing off up to $17.5 bln in asset value

* Miners, energy stocks lead declines

* Bunzl jumps on upbeat revenue forecast

* FTSE 100 down 0.7%, FTSE 250 up 0.07%
(Adds comment, updates to close)

June 15 (Reuters) - London's FTSE 100 fell on Monday but
ended well off session lows, and mid-caps cut all their losses
towards the close after a surge in new cases of the novel
coronavirus in Beijing and underwhelming data from China knocked
markets at open.

Leading losses among European peers, the FTSE 100 closed
down 0.7% but recovered from a three-week low hit during the
session.

BP Plc weighed the most on the commodity-heavy index,
sliding 2.2% after saying it would write off up to $17.5 billion
in the value of its assets. A drop in base metal prices also
weighed.

Topping the FTSE 100, business supplies distributor Bunzl
jumped 9.8% after forecasting an increase in revenue
for the first half of the year, while AstraZeneca rose
1%.

The mid-cap FTSE 250 index ended flat as losses in
mining and some consumer stocks were offset by
gains in financials and defensive sectors such as real estate
and utilities.

Concerns of a slower economic recovery rose as Beijing
reinstated curbs after an unexpected spike in cases, and on
downbeat China factory data. In Britain, data showed footprint
in shopping centres fell nearly 82% from a year earlier.

The travel sector, one of the biggest
casualties of the pandemic-driven slump in demand, was off 1.3%.
Low-cost airline easyJet shed 4.6% even as it resumed
flying for the first time since March 30.

UK stock markets last week halted a robust two-month rally
as optimism around easing lockdowns was dulled by a grim
forecast by the U.S. Federal Reserve and a resurgence in
COVID-19 cases.

Investors now await the Bank of England meeting later this
week.

"We expect them to leave the policy rate unchanged at 0.1%
and to add 100 billion of quantitative easing purchases," said
Peder Beck-Friis, portfolio manager, global macro at PIMCO, who
sees negative rates as unlikely.
(Reporting by Sagarika Jaisinghani, Shashank Nayar and Susan
Mathew in Bengaluru; additional reporting by Aaron Saldanha;
editing by Uttaresh.V; editing by Jonathan Oatis)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.